Hypothalamic inflammation in the control of metabolic function

Annual Review of Physiology

Volumn 77, Issue , 2015, Pages 131-160

  Valdearcos, Martin ^a   Xu, Allison W ^a   Koliwad, Suneil K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrocytes; Cytokines; Fatty acids; Leptin; Microglia

Indexed keywords

CYTOKINE; SATURATED FATTY ACID;

ARTICLE; ASTROCYTE; AUTOPHAGY; DIET INDUCED OBESITY; DISEASE ASSOCIATION; ENCEPHALITIS; ENDOPLASMIC RETICULUM STRESS; FEEDBACK SYSTEM; HOMEOSTASIS; HUMAN; HYPOTHALAMIC INFLAMMATION; HYPOTHALAMUS DISEASE; METABOLIC DISORDER; METABOLIC REGULATION; MICROGLIA; NERVE CELL; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; PRIORITY JOURNAL; TANYCYTE; ADVERSE EFFECTS; ANIMAL; DIET; ENERGY METABOLISM; HYPOTHALAMUS; INFLAMMATION; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DIET; ENERGY METABOLISM; HUMANS; HYPOTHALAMUS; INFLAMMATION; METABOLIC DISEASES; METABOLISM; MICROGLIA; OBESITY;

EID: 84922802034     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021014-071656     Document Type: Article

References (184)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. 2012. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307:491-97
2. Ogden CL, Carroll MD, Kit BK, Flegal KM. 2012. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 307:483-90
3. Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444:860-67
4. Odegaard JI, Chawla A. 2013. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339:172-77
5. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 112:1821-30
6. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 112:1796-808
7. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, et al. 2005. Local and systemic insulin resistance resulting from hepatic activation of IKK-βand NF-κB. Nat. Med. 11:183-90
8. Itani SI, Ruderman NB, Schmieder F, BodenG. 2002. Lipid-induced insulin resistance in humanmuscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-11
9. BandyopadhyayGK, Yu JG, Ofrecio J, Olefsky JM. 2005. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54:2351-59
10. Ehses JA, Boni-Schnetzler M, Faulenbach M, Donath MY. 2008. Macrophages, cytokines and β-cell death in Type 2 diabetes. Biochem. Soc. Trans. 36:340-42
11. Donath MY, Boni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA. 2010. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol.Metab. 21:261-67
12. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, et al. 2002. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Investig. 109:1321-26
13. UysalKT, Wiesbrock SM, MarinoMW,Hotamisligil GS. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-αfunction. Nature 389:610-14
14. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
15. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, et al. 2005. Consumption of a fatrich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146:4192-99
16. Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, et al. 2012. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Investig. 122:153-62
17. HollandWL, Bikman BT,Wang LP, Yuguang G, Sargent KM, et al. 2011. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Investig. 121:1858-70
18. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. 2008. Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 135:61-73
19. Mraz M, Haluzik M. 2014. The role of adipose tissue immune cells in obesity and low-grade inflammation. J. Endocrinol. 222:R113-27
20. Mori MA, Liu M, Bezy O, Almind K, Shapiro H, et al. 2010. A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease. Diabetes 59:2960-71
21. Morton GJ, CummingsDE, Baskin DG, BarshGS, SchwartzMW.2006. Central nervous system control of food intake and body weight. Nature 443:289-95
22. Coll AP, Farooqi IS, O'Rahilly S. 2007. The hormonal control of food intake. Cell 129:251-62
23. Sandoval D, Cota D, Seeley RJ. 2008. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu. Rev. Physiol. 70:513-35
24. Clark JT, Kalra PS, CrowleyWR, Kalra SP. 1984. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-29
25. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, et al. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-38
26. Dietrich MO, Horvath TL. 2013. Hypothalamic control of energy balance: insights into the role of synaptic plasticity. Trends Neurosci. 36:65-73
27. Saper CB, Chou TC, Elmquist JK. 2002. The need to feed: homeostatic and hedonic control of eating. Neuron 36:199-211
28. Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, et al. 2003. Hypothalamic proopiomelanocortin neurons are glucose responsive and express KATP channels. Endocrinology 144:1331-40
29. Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L. 2007. Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks? Diabetes 56:1219-27
30. Levin BE, Sullivan AC. 1987. Glucose, insulin and sympathoadrenal activation. J. Auton. Nerv. Syst. 20:233-42
31. Acheson KJ, Ravussin E,Wahren J, Jequier E. 1984. Thermic effect of glucose in man. Obligatory and facultative thermogenesis. J. Clin. Investig. 74:1572-80
32. Sakaguchi T, Bray GA. 1987. The effect of intrahypothalamic injections of glucose on sympathetic efferent firing rate. Brain Res. Bull. 18:591-95
33. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, et al. 2005. Hypothalamic KATP channels control hepatic glucose production. Nature 434:1026-31
34. Lam TK, Gutierrez-Juarez R, Pocai A, Bhanot S, Tso P, et al. 2007. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat. Med. 13:171-80
35. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. 2002. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51:271-75
36. Morgan K, Obici S, Rossetti L. 2004. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J. Biol. Chem. 279:31139-48
37. Mead JR, Irvine SA, Ramji DP. 2002. Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80:753-69
38. Wang H, Astarita G, Taussig MD, Bharadwaj KG, DiPatrizio NV, et al. 2011. Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. Cell Metab. 13:105-13
39. Milanski M, Degasperi G, Coope A, Morari J, Denis R, et al. 2009. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 29:359-70
40. Wang X, Ge A, ChengM, Guo F, Zhao M, et al. 2012. Increased hypothalamic inflammation associated with the susceptibility to obesity in rats exposed to high-fat diet. Exp. Diabetes Res. 2012:847246
41. Kleinridders A, Schenten D, Konner AC, Belgardt BF, Mauer J, et al. 2009. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 10:249-59
42. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, et al. 2007. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 5:181-94
43. Morselli E, Fuente-Martin E, Finan B, Kim M, Frank A, et al. 2014. Hypothalamic PGC-1αprotects against high-fat diet exposure by regulating ERα. Cell Rep. 9:633-45
44. KangYM,MaY,Zheng JP,ElksC, Sriramula S, et al. 2009. Brain nuclear factor-κBactivation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc. Res. 82:503-12
45. Calegari VC, Torsoni AS, Vanzela EC, Aráujo EP, Morari J, et al. 2011. Inflammation of the hypothalamus leads to defective pancreatic islet function. J. Biol. Chem. 286:12870-80
46. Purkayastha S, Zhang H, Zhang G, Ahmed Z, Wang Y, Cai D. 2011. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. PNAS 108:2939-44
47. Sharp FR, Massa SM, Swanson RA. 1999. Heat-shock protein protection. Trends Neurosci. 22:97-99
48. Choi C, Kutsch O, Park J, Zhou T, Seol DW, Benveniste EN. 2002. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol. Cell. Biol. 22:724-36
49. Degasperi GR, Romanatto T, DenisRG, AráujoEP, Moraes JC, et al. 2008.UCP2protects hypothalamic cells from TNF-α-induced damage. FEBS Lett. 582:3103-10
50. Arruda AP,MilanskiM, Coope A, Torsoni AS, Ropelle E, et al. 2011. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology 152:1314-26
51. Arruda AP, Milanski M, Romanatto T, Solon C, Coope A, et al. 2010. Hypothalamic actions of tumor necrosis factor α provide the thermogenic core for the wastage syndrome in cachexia. Endocrinology 151:683-94
52. Romanatto T, Roman EA, Arruda AP, Denis RG, Solon C, et al. 2009. Deletion of tumor necrosis factor-αreceptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J. Biol. Chem. 284:36213-22
53. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-4
54. Burgos-Ramos E, Gonzalez-Rodriguez A, Canelles S, Baquedano E, Frago LM, et al. 2012. Differential insulin receptor substrate-1 (IRS1)-related modulation of neuropeptide Y and proopiomelanocortin expression in nondiabetic and diabetic IRS2-/-mice. Endocrinology 153:1129-40
55. Thaler JP, Choi SJ, Schwartz MW, Wisse BE. 2010. Hypothalamic inflammation and energy homeostasis: resolving the paradox. Front. Neuroendocrinol. 31:79-84
56. Li J, Tang Y, Cai D. 2012. IKKβ/NF-κB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes. Nat. Cell Biol. 14:999-1012
57. Sousa-Ferreira L, de Almeida LP, Cavadas C. 2014. Role of hypothalamic neurogenesis in feeding regulation. Trends Endocrinol. Metab. 25:80-88
58. McNay DE, Briancon N, Kokoeva MV, Maratos-Flier E, Flier JS. 2012. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J. Clin. Investig. 122:142-52
59. Rolls A, Shechter R, London A, Ziv Y, Ronen A, et al. 2007. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9:1081-88
60. Boden G. 2008. Obesity and free fatty acids. Endocrinol. Metab. Clin. N. Am. 37:635-46, viii-ix
61. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, et al. 2003. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278:37041-51
62. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, et al. 2003. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44:479-86
63. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, et al. 2009. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 296:E1003-12
64. DeLany JP, Windhauser MM, Champagne CM, Bray GA. 2000. Differential oxidation of individual dietary fatty acids in humans. Am. J. Clin. Nutr. 72:905-11
65. Cintra DE, Ropelle ER, Moraes JC, Pauli JR, Morari J, et al. 2012. Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLOS ONE 7:e30571
66. Valdearcos M, Robblee MM, Benjamin DI, Nomura DK, Xu AW, Koliwad SK. 2014. Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function. Cell Rep. 9:1-15
67. Martinez de Morentin PB, Varela L, Ferno J, Nogueiras R, Dieguez C, Lopez M. 2010. Hypothalamic lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801:350-61
68. Benoit SC, Kemp CJ, Elias CF, Abplanalp W, Herman JP, et al. 2009. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-subcellular localization in rodents. J. Clin. Investig. 119:2577-89
69. Borg ML, Omran SF,Weir J,Meikle PJ, Watt MJ. 2012. Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice. J. Physiol. 590:4377-89
70. Romanatto T, Cesquini M, Amaral ME, Roman EA, Moraes JC, et al. 2007. TNF-α acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient-effects on leptin and insulin signaling pathways. Peptides 28:1050-58
71. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, et al. 1997. Targeted disruption of the tumor necrosis factor-αgene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-31
72. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, et al. 2011. Inflammasome is a central player in the induction of obesity and insulin resistance. PNAS 108:15324-29
73. Vandanmagsar B, Youm YH, Ravussin A,Galgani JE, Stadler K, et al. 2011. TheNLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17:179-88
74. Wen H, Gris D, Lei Y, Jha S, Zhang L, et al. 2011. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12:408-15
75. Schroder K, Zhou R, Tschopp J. 2010. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327:296-300
76. LamkanfiM, Kanneganti TD. 2012. The inflammasome: a remote control for metabolic syndrome. Cell Res. 22:1095-98
77. Ropelle ER, FloresMB, Cintra DE, Rocha GZ, Pauli JR, et al. 2010. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKβand ER stress inhibition. PLOS Biol. 8:e1000465
78. Gotoh K, Inoue M, Masaki T, Chiba S, Shimasaki T, et al. 2012. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes 61:1994-2003
79. Butti E, Bergami A, Recchia A, Brambilla E, Del Carro U, et al. 2008. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery inmousemodels of multiple sclerosis. Gene Ther. 15:504-15
80. Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE. 1999. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-Amyloid and prion proteins. J. Neurosci. 19:928-39
81. Oh-I S, Thaler JP, Ogimoto K,Wisse BE,Morton GJ, et al. 2010. Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am. J. Physiol. Endocrinol. Metab. 299(1):E47-53
82. Hotamisligil GS. 2010. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900-17
83. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, et al. 2004. Translational repression mediates activation of nuclear factor κB by phosphorylated translation initiation factor 2. Mol. Cell. Biol. 24:10161-68
84. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. 2006. Autocrine tumor necrosis factor α links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-κB activation and down-regulation of TRAF2 expression. Mol. Cell. Biol. 26:3071-84
85. Yamazaki H, Hiramatsu N, Hayakawa K, Tagawa Y, Okamura M, et al. 2009. Activation of the Akt-NF-κB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J. Immunol. 183:1480-87
86. Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, et al. 2009. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9:35-51
87. Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, et al. 2008. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57:1071-77
88. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, et al. 2008. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1βproduction. Nature 456:264-68
89. Zhou L, AonMA, Almas T, Cortassa S, Winslow RL, O'Rourke B. 2010. A reaction-diffusion model of ROS-induced ROS release in a mitochondrial network. PLOS Comput. Biol. 6:e1000657
90. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, et al. 2011. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12:222-30
91. Zhou R, Yazdi AS, Menu P, Tschopp J. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221-25
92. Raichle ME, Gusnard DA. 2002. Appraising the brain's energy budget. PNAS 99:10237-39
93. Melov S. 2004. Modeling mitochondrial function in aging neurons. Trends Neurosci. 27:601-6
94. Kaushik S, Rodriguez-Navarro JA, Arias E, Kiffin R, Sahu S, et al. 2011. Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab. 14:173-83
95. Benani A, Troy S, CarmonaMC, Fioramonti X, Lorsignol A, et al. 2007. Role formitochondrial reactive oxygen species in brain lipid sensing: redox regulation of food intake. Diabetes 56:152-60
96. Leloup C, Magnan C, Benani A, Bonnet E, Alquier T, et al. 2006. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes 55:2084-90
97. Yorimitsu T, Klionsky DJ. 2005. Autophagy: molecular machinery for self-eating. Cell Death Differ. 12(Suppl. 2):1542-52
98. Butler D, Bahr BA. 2006. Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy. Antioxid. Redox Signal. 8:185-96
99. Yorimitsu T, Nair U, Yang Z, Klionsky DJ. 2006. Endoplasmic reticulum stress triggers autophagy. J. Biol. Chem. 281:30299-304
100. Meng Q, Cai D. 2011. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IκB kinase β(IKKβ)/NF-κB pathway. J. Biol. Chem. 286:32324-32
101. Fujishima Y, Nishiumi S, Masuda A, Inoue J, Nguyen NM, et al. 2011. Autophagy in the intestinal epithelium reduces endotoxin-induced inflammatory responses by inhibiting NF-κB activation. Arch. Biochem. Biophys. 506:223-35
102. Singh RB, Gupta S, Dherange P, DeMeester F,Wilczynska A, et al. 2012. Metabolic syndrome: a brain disease. Can. J. Physiol. Pharmacol. 90:1171-83
103. Choi SJ, Kim F, Schwartz MW, Wisse BE. 2010 Cultured hypothalamic neurons are resistant to inflammation and insulin resistance induced by saturated fatty acids. Am. J. Physiol. Endocrinol. Metab.
104. MayerCM,BelshamDD.2010. Palmitate attenuates insulin signaling and induces endoplasmic reticulum stress and apoptosis in hypothalamic neurons: rescue of resistance and apoptosis through adenosine 5- monophosphate-Activated protein kinase activation. Endocrinology 151:576-85
105. ArkanMC, Hevener AL,Greten FR, Maeda S, Li ZW, et al. 2005. IKK-βlinks inflammation to obesityinduced insulin resistance. Nat. Med. 11:191-98
106. Purkayastha S, Zhang G, Cai D. 2011. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-βand NF-κB. Nat. Med. 17:883-87
107. Jang PG, Namkoong C, Kang GM, Hur MW, Kim SW, et al. 2010. NF-κB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness-And leptin-induced anorexia. J. Biol. Chem. 285:9706-15
108. Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Kocak E, et al. 2013. Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339:1092-95
109. Compan V, Baroja-Mazo A, Lopez-Castejon G, Gomez AI, Martinez CM, et al. 2012. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37:487-500
110. Ramos HJ, LanteriMC, Blahnik G, Negash A, SutharMS, et al. 2012. IL-1βsignaling promotes CNSintrinsic immune control ofWest Nile virus infection. PLOS Pathog. 8:e1003039
111. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, et al. 2007. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55:443-52
112. de Rivero Vaccari JP, Lotocki G, Marcillo AE, Dietrich WD, Keane RW. 2008. A molecular platform in neurons regulates inflammation after spinal cord injury. J. Neurosci. 28:3404-14
113. Ransohoff RM, Brown MA. 2012. Innate immunity in the central nervous system. J. Clin. Investig. 122:1164-71
114. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J. 2013. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 36:209-17
115. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, et al. 2012. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74:691-705
116. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, et al. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456-58
117. Gemma C, Bachstetter AD. 2013. The role of microglia in adult hippocampal neurogenesis. Front. Cell. Neurosci. 7:229
118. Sierra A, Abiega O, Shahraz A, Neumann H. 2013. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front. Cell. Neurosci. 7:6
119. Lehnardt S,Massillon L, Follett P, Jensen FE, Ratan R, et al. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. PNAS 100:8514-19
120. Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, et al. 1998. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63:740-45
121. Goncalves J, Ribeiro CF, Malva JO, Silva AP. 2012. Protective role of neuropeptide Y Y2 receptors in cell death and microglial response following methamphetamine injury. Eur. J. Neurosci. 36:3173-83
122. FerreiraR, SantosT, ViegasM,CortesL, Bernardino L, et al. 2011. Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells. J. Neuroinflamm. 8:169
123. Oh IS, Thaler JP, Ogimoto K, Wisse BE, Morton GJ, Schwartz MW. 2010. Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am. J. Physiol. Endocrinol. Metab. 299:E47-53
124. Amano SU, Cohen JL, Vangala P, Tencerova M, Nicoloro SM, et al. 2014. Local proliferation of macrophages contributes to obesity-Associated adipose tissue inflammation. Cell Metab. 19:162-71
125. Ito A, Suganami T, Yamauchi A, Degawa-Yamauchi M, Tanaka M, et al. 2008. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J. Biol. Chem. 283:35715-23
126. Varvel NH, Grathwohl SA, Baumann F, Liebig C, Bosch A, et al. 2012. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. PNAS 109:18150-55
127. Elmore MR,Najafi AR,Koike MA,Dagher NN, Spangenberg EE, et al. 2014. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82:380-97
128. Lafrance V, Inoue W, Kan B, Luheshi GN. 2010. Leptin modulates cell morphology and cytokine release in microglia. Brain Behav. Immun. 24:358-65
129. Tang CH, Lu DY, Yang RS,TsaiHY, KaoMC, et al. 2007. Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-κB, and p300 pathway in microglia. J. Immunol. 179:1292-302
130. Yi CX, Al-Massadi O, Donelan E, Lehti M, Weber J, et al. 2012. Exercise protects against high-fat diet-induced hypothalamic inflammation. Physiol. Behav. 106:485-90
131. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, et al. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9:857-65
132. Hanamsagar R, Torres V, Kielian T. 2011. Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia. J. Neurochem. 119:736-48
133. Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, et al. 2013. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 18:519-32
134. Sofroniew MV, Vinters HV. 2010. Astrocytes: biology and pathology. Acta Neuropathol. 119:7-35
135. Oberheim NA, Wang X, Goldman S, Nedergaard M. 2006. Astrocytic complexity distinguishes the human brain. Trends Neurosci. 29:547-53
136. Kim JG, Suyama S, Koch M, Jin S, Argente-Arizon P, et al. 2014. Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding. Nat. Neurosci. 17:908-10
137. Fuente-Martin E, Garcia-Caceres C, Granado M, de Ceballos ML, Sanchez-Garrido MA, et al. 2012. Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J. Clin. Investig. 122:3900-13
138. Garcia-Caceres C, Fuente-Martin E, Burgos-Ramos E, Granado M, Frago LM, et al. 2011. Differential acute and chronic effects of leptin on hypothalamic astrocyte morphology and synaptic protein levels. Endocrinology 152:1809-18
139. Garcia-Caceres C, Yi CX, Tschop MH. 2013. Hypothalamic astrocytes in obesity. Endocrinol. Metab. Clin. N. Am. 42:57-66
140. Levin BE, Magnan C, Dunn-Meynell A, Le Foll C. 2011. Metabolic sensing and the brain: who, what, where, and how? Endocrinology 152:2552-57
141. Shen L, Tso P, Wang DQ, Woods SC, Davidson WS, et al. 2009. Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats. Physiol. Behav. 98:223-28
142. Blazquez C, Sanchez C, Velasco G, Guzman M. 1998. Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes. J. Neurochem. 71:1597-606
143. Marino JS, Xu Y, Hill JW. 2011. Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol. Metab. 22:275-85
144. Gupta S,Knight AG, Gupta S,Keller JN, Bruce-Keller AJ. 2012. Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J. Neurochem. 120:1060-71
145. Saura J. 2007. Microglial cells in astroglial cultures: a cautionary note. J. Neuroinflamm. 4:26
146. Minkiewicz J, de Rivero Vaccari JP, Keane RW. 2013. Human astrocytes express a novel NLRP2 inflammasome. Glia 61:1113-21
147. Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, et al. 2012. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149:847-59
148. Lee DA, Bedont JL, Pak T,Wang H, Song J, et al. 2012. Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche. Nat. Neurosci. 15:700-2
149. Bolborea M, Dale N. 2013. Hypothalamic tanycytes: potential roles in the control of feeding and energy balance. Trends Neurosci. 36:91-100
150. Frayling C, Britton R, Dale N. 2011. ATP-mediated glucosensing by hypothalamic tanycytes. J. Physiol. 589:2275-86
151. Dale N. 2011. Purinergic signaling in hypothalamic tanycytes: potential roles in chemosensing. Semin. Cell Dev. Biol. 22:237-44
152. Balland E, Dam J, Langlet F, Caron E, Steculorum S, et al. 2014. Hypothalamic tanycytes are an ERKgated conduit for leptin into the brain. Cell Metab. 19:293-301
153. Nadeau S, Rivest S. 1999. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93:1449-64
154. Nishibori M, Nakaya N, Mori S, Saeki K. 1997. Immunohistochemical localization of macrophage migration inhibitory factor (MIF) in tanycytes, subcommissural organ and choroid plexus in the rat brain. Brain Res. 758:259-62
155. Yuan M, Konstantopoulos N, Lee J,Hansen L, Li ZW, et al. 2001. Reversal of obesity-And diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293:1673-77
156. Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, et al. 2011. TNF-α antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J. Clin. Endocrinol. Metab. 96:E146-50
157. SolomonDH, Massarotti E, Garg R, Liu J,Canning C, Schneeweiss S. 2011. Association between diseasemodifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 305:2525-31
158. Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K. 2008. The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149:2208-18
159. Osborn O, Brownell SE, Sanchez-Alavez M, Salomon D, Gram H, Bartfai T. 2008. Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine 44:141-48
160. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, et al. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356:1517-26
161. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS. 2004. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10:734-38
162. Howard JK, Flier JS. 2006. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab. 17:365-71
163. Zabolotny JM,Kim YB,Welsh LA,Kershaw EE, Neel BG,Kahn BB. 2008. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem. 283:14230-41
164. SabioG, Cavanagh-Kyros J, Barrett T, Jung DY, Ko HJ, et al. 2010. Role of the hypothalamic-pituitarythyroid axis in metabolic regulation by JNK1. Genes Dev. 24:256-64
165. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, et al. 2002. A central role for JNK in obesity and insulin resistance. Nature 420:333-36
166. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, et al. 2007. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 6:386-97
167. Mori H, Hanada R, Hanada T, Aki D, Mashima R, et al. 2004. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10:739-43
168. Milanski M, Arruda AP, Coope A, Ignacio-Souza LM, Nunez CE, et al. 2012. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61:1455-62
169. Minami SS, Sun B, Popat K, Kauppinen T, Pleiss M, et al. 2012. Selective targeting of microglia by quantum dots. J. Neuroinflamm. 9:22
170. Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, et al. 2013. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB andGnRH. Nature 497:211-16
171. Frakes AE, Ferraiuolo L,Haidet-Phillips AM, Schmelzer L, Braun L, et al. 2014. Microglia inducemotor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron 81:1009-23
172. Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, et al. 2013. Microglia promote learningdependent synapse formation through brain-derived neurotrophic factor. Cell 155:1596-609
173. Goldmann T, Wieghofer P, Muller PF, Wolf Y, Varol D, et al. 2013. A new type of microgliagene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat. Neurosci. 16:1618-26
174. Tesz GJ, Aouadi M, Prot M, Nicoloro SM, Boutet E, et al. 2011. Glucan particles for selective delivery of siRNA to phagocytic cells in mice. Biochem. J. 436:351-62
175. Aouadi M, Tencerova M, Vangala P, Yawe JC, Nicoloro SM, et al. 2013. Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice. PNAS 110:8278-83
176. Ladeby R, Wirenfeldt M, Garcia-Ovejero D, Fenger C, Dissing-Olesen L, et al. 2005. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 48:196-206
177. Flugel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, et al. 2001. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14:547-60
178. Hanisch UK, Kettenmann H. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10:1387-94
179. Buckman LB, Hasty AH, Flaherty DK, Buckman CT, Thompson MM, et al. 2014. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav. Immun. 35:33-42
180. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. 2007. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10:1538-43
181. Amir RE, Van den Veyver IB,Wan M, Tran CQ, Francke U, Zoghbi HY 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein2. Nat. Genet. 23:185-88
182. Van den Veyver IB, Zoghbi HY. 2001. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome. Brain Dev. 23(Suppl. 1):147-51
183. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, et al. 2011. A role for glia in the progression of Rett's syndrome. Nature 475:497-500
184. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, et al. 2012. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484:105-9